Adenoviral expression of p53 represses telomerase activity through down- regulation of human telomerase reverse transcriptase transcription

Clinical Cancer Research

Volumn 6, Issue 4, 2000, Pages 1239-1247

  Kanaya, Taro ^a   Kyo, Satoru ^a   Hamada, Katsuyuki ^b   Takakura, Masahiro ^a   Kitagawa, Yasuhide ^a   Harada, Hironobu ^b   Inoue, Masaki ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; TELOMERASE; TRANSCRIPTASE; VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; ARTICLE; BINDING SITE; CELL GROWTH; CELL PROLIFERATION; ENZYME ACTIVITY; EPITHELIUM CELL; GROWTH INHIBITION; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TELOMERE; TRANSCRIPTION REGULATION; VIRUS EXPRESSION;

ADENOVIRIDAE; APOPTOSIS; BINDING SITES; CATALYTIC DOMAIN; CELL DIVISION; DNA-BINDING PROTEINS; DOWN-REGULATION; GENE EXPRESSION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENETIC VECTORS; HUMANS; MUTATION; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; RNA; RNA, MESSENGER; SP1 TRANSCRIPTION FACTOR; TELOMERASE; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034048726     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Greider, C. W. Telomere length regulation. Annu. Rev. Biochem., 65: 337-365, 1996.
2. Greider, C. W. Chromosome first aid. Cell, 67: 645-647, 1991.
3. Watson, J. D. Origin of concatameric T4 DNA. Nature (Lond.), 239: 197-201, 1972.
4. Counter, C. M., Avilion, A. A., LeFeuvre, C. E., Stewart, N. G., Greider, C. W., and Harley, C. B. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J., 11: 1921-1929, 1992.
5. Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Oviello, G. M., Wright, W. E., Weinrich, S. L., and Shay, J. W. Specific association of human telomerase activity with immortal cells and cancer. Science (Washington DC), 266: 2011-2015, 1994.
6. Shay, J. W., and Bacchetti, S. A survey of telomerase activity in human cancer. Eur. J. Cancer, 33: 787-791, 1997.
7. Hiyama, K., Hirai, Y., Kyoizumi, S., Yamakido, M., Inai, K., Gazdar, A. F., Piatyszek, M. A., and Shay, J. W. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J. Immunol., 755: 3711-3715, 1995.
8. Harle-Bachor, C., and Boukamp, P. Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes. Proc. Natl. Acad. Sci. USA, 93: 6476-6481, 1996.
9. Kyo, S., Takakura, M., Kohama, T., and Inoue, M. Telomerase activity in human endometrium. Cancer Res., 57: 610-614, 1997.
10. Tanaka, M., Kyo, S., Takakura, M., Kanaya, T., Sagawa, T., Yamashita, K., Hiyama, E., and Inoue, M. Expression of telomerase activity in human endometrium is localized to epithelial glandular cells and regulated in a menstrual phase-dependent manner correlated with cell proliferation. Am. J. Pathol., 153: 1985-1991, 1998.
11. Albanell, J., Han, W., Mellado, B., Gunawardane, R., Scher, H. I., Dmitrovsky, E., and Moore, M. A. S. Telomerase activity is repressed during differentiation of maturation-sensitive but not resistant human tumor cell lines. Cancer Res., 56: 1503-1508, 1996.
12. Holt, S. E., Wright, W. E., and Shay, J. W. Regulation of telomerase activity in immortal cell lines. Mol. Cell. Biol., 16: 2932-2939, 1996.
13. Feng, J., Funk, W. D., Wang, S. S., Weinrich, A. A. A., Chiu, C. P., Adams. R. R., Chang, E., Allsopp, R. C., Yu, J., Le, S., West, M. D., Harley, C. B., Andrew, W. H., Greider, C. W., and Villeponteau, B. The RNA component of human telomerase. Science (Washington DC), 269: 1236-1241, 1995.
14. Harrington, L., McPhail, T., Mar, V. Zhou, W., Oulton, R., Bass, M. B., Arruda I., and Robinson, M. O. A mammalian telomerase-associated protein. Science (Washington DC), 275: 973-977, 1997.
15. Nakayama, J., Saito, M., Nakamura, H., Matsuura, A., and Ishikawa, F. TLP1: a gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family. Cell, 88: 875-884, 1997.
16. Meyerson, M., Counter, C. M., Eaton, E. N., Ellisen, L. W., Steiner, P., Caddle, S. D., Ziaugra, L., Beijersbergen, R. L., Davidoff, M. J., Liu, Q., Bacchetti, S., Haber, D. A., and Weinberg, R. A. HEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell, 90: 785-795, 1997.
17. Nakamura, T. M., Morin, G. B., Chapman, K. B., Weinrich, S. L., Andrews, W. H., Lingner, J., Harley, C. B., and Cech, T. R. Telomerase catalytic subunit homologs from fission yeast and human. Science (Washington DC), 277: 955-959, 1997.
18. Takakura, M., Kyo, S., Kanaya, T., Tanaka, M., and Inoue, M. Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer. Cancer Res., 58: 1558-1561, 1998.
19. Kyo, S., Kanaya, T., Takakura, M., Tanaka, M., and Inoue, M. Human telomerase reverse transcriptase as a critical determinant of telomerase activity in normal and malignant endometrial tissues. Int. J. Cancer, 80: 60-63, 1999.
20. Kyo, S., Kanaya, T., Takakura, M., Tanaka, M., Yamashita, A., Inoue, H., and Inoue, M. Expression of human telomerase subunits in ovarian malignant, borderline and benign tumors. Int. J. Cancer, 80: 804-809, 1999.
21. Weinrich, S. L., Pruzan, R., Ma, L., Ouellette, M., Tesmer, V. M., Holt, S. E., Bodnar, A. G., Lichtsteiner, S., Kim, N. W., Trager, J. B., Taylor, R. D., Carlos, R., Andrews, W. H., Wright, W. E., Shay, J. W., Harley, C. B., and Morin, G. B. Reconstitution of human telomerase with template RNA component hTERC and the catalytic protein subunit hTERT. Nat. Genet., 17: 498-502, 1997.
22. Nakayama, J., Tahara, H., Tahara, E., Saito, M., Nakamura, H., Nakanishi, T., Tahara, E., Ide, T., and Ishikawa, F. Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat. Genet., 18: 65-68, 1998.
23. Bodnar, A. G., Ouellette, M., Frolkins, M., Holt, S. E., Chiu, C. P., Morin, G. B., Harley. C. B., Shay, J. W., Lichtsteiner, S., and Wright, W. E. Extension of life-span by introduction of telomerase into normal human cells. Science (Washington DC), 279: 349-352, 1998.
24. Gollahon, L. S., and Shay, J. W. Immortalization of human mammary epithelial cells transfected with mutant p53 (273his). Oncogene, 15: 715-725, 1996.
25. Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., and Howley, P. M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell, 63: 1129-1136. 1990.
26. Klingelhutz, A. J., Foster, S. A., and McDougall, J. K. Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature (Lond.), 380: 79-82, 1996.
27. Zhang, W. W., Fang, X. F., Mazur, W., French, B. A., Georges, R. N., and Roth, J. A. High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus. Cancer Gene Ther., 1: 4-15, 1994.
28. Wang, T. T. Y., and Phang, J. M. Effects of estrogen on apoptotic pathways in human breast cancer cell line MCF-7. Cancer Res., 55: 2487-2489, 1995.
29. Takakura, M., Kyo, S., Kanaya, T., Hirano, H., Takeda, J., Yutsudo, M., and Inoue, M. Cloning of human telomerase reverse transcriptase gene promoter and identification of proximal core promoter essential for transcriptional activation of hTERT in immortalized and cancer cells. Cancer Res., 59: 551-559, 1999.
30. Baker, S. J., Markowitz, S., Fearon, E. R., Willson, J. K., and Vogelstein, B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science (Washington DC), 249: 912-915, 1990.
31. Graham, F. L., and Van der Eb, A. J. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology, 52: 456-467, 1973.
32. Mandal, M., and Kumar, R. Bcl-2 modulates telomerase activity. J. Biol. Chem., 272: 14183-14187, 1997.
33. Miyashita, T., Krajewski, S., Krajewska, M., Wang, H. G., Lin, H. K., Liebermann, D. A., Hoffman, B., and Reed, J. C. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene, 9: 1799-1805, 1994.
34. Wu, K. J., Grandori, C., Amacker, M., Simon-Vermot, N., Polack, A., Lingner, J., and Dalla-Favera, R. Direct activation of TERT transcription by c-MYC. Nat. Genet., 21: 220-224, 1994.
35. Greenberg, R. A., Hagan, R. C., Deng, H., Xiao, Q., Hann, S. R., Adams, R. R., Lichtsteiner, S., Chin, L., Morin, G. B., and DePinho, R. A. Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation. Oncogene, 18: 1219-1226, 1999.
36. El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell, 75: 817-825, 1993.
37. Miyashita, T., and Reed, J. C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell, 80: 293-299, 1995.
38. Polyak, K., Xia, Y., Zweier, J. L., Kinzler, K. W., and Vogelstein, B. A model for p53-induced apoptosis. Nature (Lond.), 389: 300-305, 1997.
39. Ohlsson, C., Kley, N., Werner, H., and Leroith, D. p53 regulates insulin-like growth factor-I (IGF-I) receptor expression and IGF-I-induced tyrosine phosphorylation in an osteosarcoma cell line: intereaction between p53 and Sp1. Endocrinology, 139: 1101-1107, 1998.
40. Janknecht, R., and Hunter, T. Versatile molecular glue. Transcriptional control. Curr. Biol., 6: 951-954, 1996.
41. Avantaggiati, M. L., Ogryzko, V., Gardner, K., Giordano, A., Levine, A. S., and Kelly, K. Recruitment of p300/CBP in p53-dependent signal pathways. Cell, 89: 1175-1184, 1997.
42. Kondo, S., Kondo, Y., Li, G., Silverman, R. H., and Cowell, J. K. Targeted therapy of human malignant glioma in a mouse model by 2-5A antisense directed against telomerase RNA. Oncogene, 16: 3323-3330, 1998.